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pt received January 4, 201his study sought to test the hypothesis that semiautomated calculation of left ventricular global longitudinal strain
(GLS) can identify high-risk subjects among patients with myocardial infarctions (MIs) with left ventricular ejection
fractions (LVEFs) >40%.Background LVEF is a key determinant in decision making after acute MI, yet it is relatively indiscriminant within the normal
range. Novel echocardiographic deformation parameters may be of particular clinical relevance in patients with
relatively preserved LVEFs.Methods Patients with MIs and LVEFs >40% within 48 h of admission for coronary angiography were prospectively included.
All patients underwent echocardiography with semiautomated measurement of GLS. The primary composite
endpoint (all-cause mortality and hospitalization for heart failure) was analyzed using Cox regression analyses. The
secondary endpoints were cardiac death and heart failure hospitalization.Results A total of 849 patients (mean age 61.9  12.0 years, 73% men) were included, and 57 (6.7%) reached the primary
endpoint (median follow-up 30 months). Signiﬁcant prognostic value was found for GLS (hazard ratio [HR]: 1.20;
95% conﬁdence interval [CI]: 1.10 to 1.32; p < 0.001). GLS> 14% was associated with a 3-fold increase in risk for
the combined endpoint (HR: 3.21; 95% CI: 1.82 to 5.67; p < 0.001). After adjustment for other variables, GLS
remained independently related to the combined endpoint (HR: 1.14; 95% CI: 1.04 to 1.26; p ¼ 0.007). For the
secondary endpoints, GLS > 14% was signiﬁcantly associated with cardiovascular death (HR: 12.7; 95% CI: 3.0 to
54.6; p < 0.001) and heart failure hospitalization (HR: 5.31; 95% CI: 1.50 to 18.82; p < 0.001).Conclusions Assessment of GLS using a semiautomated algorithm provides important prognostic information in patients with
LVEFs >40% above and beyond traditional indexes of high-risk MI. (J Am Coll Cardiol 2013;61:2365–73) ª 2013
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2366monitoring and alterations in
available therapies and as a se-
lection criterion for future ran-
domized studies testing new
therapies.
Echocardiographic strain imag-
ing can provide a quantitative
measure of subtle LV dysfunction
in the setting of preserved LVEF.
The main focus has been on the
assessment of global longitudi-
nal strain (GLS), reﬂecting the
function of subendocardial longi-
tudinally oriented myocardial ﬁ-
bers, which are especially sensitive
to ischemia and increased wall
stress (4). Infarct size has been
shown to correlate with GLS
(5,6), and several studies have
documented a relation between
GLS and heart failure (HF) with
preserved ejection fraction (7,8).
Previous studies have shown, that
GLS adds prognostic value in
chronicHF (9) and inpatientswith
high-risk MI and ST-segment
elevation myocardial infarction
(STEMI) (10–12) over the entirespectrum of systolic function. However, to the best of
our knowledge, no previous prospective study has focused on
the prognostic utility of semiautomated GLS assessment in
patients with MIs and normal to only modestly reduced
LVEFs.
Therefore, we hypothesized that semiautomated GLS
assessment could identify high-risk patients with MIs with
normal to modestly reduced LVEFs beyond traditional risk
factors.Methods
Study design and patient population. We conducted
a prospective study of patients referred for invasive coronary
angiography for either STEMI or non-STEMI at 2 tertiary
cardiac centers in the Copenhagen region. All patients
provided written informed consent before transthoracic
echocardiographic examination. Exclusion criteria were age
<18 years, noncardiac disease with a life expectancy <1 year,
and inability to provide written informed consent.
Furthermore, echocardiograms obtained from patients with
atrial ﬁbrillation, paced rhythm, or severe aortic stenosis
noted at the time of echocardiographic examination was
excluded from the analyses.
On the basis of hospital records obtained on admission,
information on diabetes mellitus, hypertension, history of
ischemic heart disease, and prior MI was registered. Find-
ings on coronary angiography, including culprit lesion,number of diseased vessels, left main coronary artery
involvement, and type of revascularization (percutaneous
coronary intervention, coronary artery bypass grafting, or no
intervention) were registered. Objective signs of HF at
presentation or during hospitalization were scored according
to the Killip classiﬁcation scheme (13). Additional bio-
chemical workup included creatinine, hemoglobin, and peak
troponin during the hospital stay. Peak troponin I was
measured in 226 patients (27%) and peak troponin T in 622
patients (73%). Estimated glomerular ﬁltration rate (eGFR)
was measured from the 4-variable Modiﬁcation of Diet in
Renal Disease formula (14). The study was approved by the
Regional Scientiﬁc Ethics Committee (reference number
H-D-2009-063).
Echocardiography. Echocardiography was performed within
48 h of admission to the tertiary center. Echocardiographic
cine loops were obtained by recording 3 consecutive heart
cycles. All examinations were performed using a Vivid e9
(GE Vingmed Ultrasound AS, Horten, Norway). Images
were obtained at a frame rate of at least 60 frames/s and
digitally transferred to a remote workstation for ofﬂine
analysis (EchoPAC BT 11.1.0, GE Vingmed Ultrasound
AS). All analyses were performed by a single experienced
operator (M.E.) blinded to follow-up information.
Two-dimensional parasternal images were used to deter-
mine LV dimensions and wall thickness. Left atrial volume
index (LAVI) was determined from the biplane area-length
method, and LVEF was determined using the biplane
Simpson model. Left ventricular mass index (LVMI) was
calculated from the LV linear dimensions in the parasternal
view. Volumetric and dimensional measurements of the left
ventricle and left atrium were indexed to body surface area
when appropriate. All volumetric analyses were performed in
accordance with European Association of Echocardiography
and American Society of Echocardiography recommenda-
tions (15).
Color Doppler examination of the mitral valve was per-
formed in the apical window, and if more than trivial mitral
regurgitation (MR) was present, it was quantiﬁed by
calculating the effective regurgitant oriﬁce area using the
proximal isovelocity surface area method. Effective regur-
gitant oriﬁce area <0.20 cm2 was considered mild, 0.20 to
0.40 cm2 moderate, and >0.40 cm2 severe MR. Doppler
recordings of mitral inﬂow were performed by placing a
2.5-mm sample volume at the tip of the mitral valve leaﬂets
and recording the pulsed-waveDoppler signal. Peak velocities
of early (E) and atrial (A) diastolic ﬁlling and mitral valve
deceleration time were measured, and the E/A ratio was
calculated. Pulsed-wave tissue Doppler imaging recordings
were obtained at the lateral and medial mitral annulus using
a 2.5-mm sample volume with measurements of myocardial
peak early velocity (e0). The mean E/e0 ratio was calculated
from the mean of lateral and medial values of e0 (16).
Strain analysis. Two-dimensional speckle tracking was
performed using a semiautomatic algorithm (Automated
Function Imaging, GE Healthcare, Milwaukee, Wisconsin).
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1 apical) was performed in each of the 3 apical projections,
enabling the software to semiautomatically track the
myocardium throughout the heart cycle. The region of
interest was adjusted to cover the thickness of the myocar-
dium. Aortic valve closure was identiﬁed on continuous-
wave Doppler recording through the aortic valve. The left
ventricle was subsequently divided into 17 segments
covering the entire myocardium. Careful inspection of
tracking and manual correction, if needed, was performed,
and in case of unsatisfactory tracking, the segment was
excluded from the analysis. The Automated Function
Imaging algorithm allowed GLS to be calculated for each of
the 3 apical projections if at least 5 of 6 segments were
sufﬁciently tracked. The algorithm then calculated overall
GLS as the mean value of all 3 projections. If GLS could be
assessed in only 2 of 3 apical projections, we calculated
overall GLS as the mean of these 2 values. If GLS could not
be assessed in at least 2 of the apical projections, the patient
examination was classiﬁed as having image quality insufﬁ-
cient for strain measurements.
Follow-up and endpoint deﬁnition. The primary outcome
was a composite of death from any cause and hospitalization
for HF. Information on all-cause mortality was obtained
from the Danish Civil Registration System. Information on
HF hospitalization was obtained from a systematic review of
all hospital admissions after the index MI. Hospitalization
for HF was deﬁned as admission because of dyspnea with
objective signs of pulmonary congestion and treatment with
intravenous diuretic agents. Veriﬁcation of HF hospitaliza-
tion was performed by an independent reviewer blinded to
echocardiographic information relating to index MI. Cause
of death was ascertained from hospital records and classiﬁed
as either cardiac or noncardiac. The secondary endpoints
were cardiac death, hospitalization for HF, and new MI.
Statistical analysis. All data are reported as mean  SD or
median (interquartile range). Baseline clinical and echocar-
diographic data were analyzed according to GLS quartiles,
with categorical and continuous data tested using Cochran-
Armitage trend tests and analysis of variance, respectively.
All tests were 2 sided, and statistical signiﬁcance was deﬁned
as p < 0.05. Interobserver and intraobserver reproducibility
was assessed in 20 randomly selected patients using Bland-
Altman analysis.
The optimal predictive cutoff value of GLS was found by
maximizing the partial likelihood, and the Kaplan Meier
estimate for the combined endpoint was plotted using this
cutoff value. Univariate Cox proportional hazard regression
analyses was performed to analyze the relationships between
covariates with known or suspected relationships with the
primary endpoint. Backward elimination was performed on
a model consisting of all the covariates from the univariate
analyses to obtain a parsimonious model.
The relative importance of GLS in relation to echocar-
diographic parameters was assessed in a model adjusted for
LAVI, E/e0 ratio, moderate to severe MR, LVMI, LVEF,and wall motion score index (WMSI), which have all been
associated with outcome after acute MI. To assess the
importance of GLS in relation to clinical covariates, we
adjusted in a multivariate Cox model for age, diabetes,
history of hypertension, Killip class >1, eGFR, troponin,
and infarct classiﬁcation as forced-entry covariates. This was
based on previous studies that considered both diabetes and
Killip class >1 as valid criteria for classiﬁcation of high-risk
MI despite preserved LVEF (17) and infarct classiﬁcation to
assess the possible inﬂuence of STEMI or non-STEMI.
Peak troponin was entered as quartiles of either troponin T
or troponin I. The multivariate models were assessed for
assumptions of linearity and proportionality with cumulated
Martingale and Schoenfeld residuals, respectively. No
violations of linearity or proportionality were found. Incre-
mental model performance was assessed with 2 log
likelihood.
Reclassiﬁcation analysis with arbitrary risk categories of
0% to 5%, 5% to 10%, and >10% was used to assess inte-
grated diagnostic improvement (IDI) and net reclassiﬁcation
index (NRI) when adding GLS to the conventional
measures of LV systolic function (LVEF and WMSI) (18).
Furthermore, IDI and NRI were evaluated when adding
GLS higher than the cutoff value to a model consisting of
Killip class >1, diabetes, LVEF, and WMSI. This was
based on the presumption that these covariates carry the
most impact in daily clinical decision making and risk
stratiﬁcation in patients with acute MIs and LVEFs >40%.
To evaluate the direct effect of GLS on the secondary
outcomes of cardiac death, HF admission, and new MI, we
performed separate univariate and multivariate Cox models
for each secondary endpoint. Cumulative incidence curves
were drawn for both outcomes stratiﬁed according to the
optimal predictive value of GLS using cause-speciﬁc Cox
regression technique allowing for the competing risk. For
the cumulative incidence curve for cardiac death, the
competing risk was death from other causes, and for HF
admission, the competing risk was death from all causes. All
analyses were performed using R software (R Development
Core Team) with the Survival, RiskRegression, and Publish
packages.Results
Baseline characteristics. A total of 1,110 patients with
MIs were prospectively included. Fifty-three patients were
excluded because of atrial ﬁbrillation (n ¼ 40), ventricular
paced rhythm (n ¼ 5), and severe aortic stenosis (n ¼ 8).
Of the 1,057 patients remaining, 51 (5%) were excluded
because of poor image quality. Finally, 157 patients (16%)
had LVEF 40%, leaving 849 patients (84%) with LVEFs
>40% (mean age 61.9  12.0, 73% men) for analysis. The
baseline clinical characteristics of the patients with LVEFs
>40% are shown according to quartiles of GLS in Table 1.
The mean value of GLS in patients with LVEFs >40%
was 14.5  3.1%. Impaired GLS was associated with
Table 1 Baseline Clinical Characteristics in Patients With LVEFs >40% According to Quartiles of GLS
Characteristic
GLS (%)
p Value
<16.7
(n ¼ 212)
16.7 to 14.6
(n ¼ 212)
14.6 to 12.1
(n ¼ 213)
>12.1
(n ¼ 212)
Age (yrs) 60.2  11.5 61.5  11.5 61.4  12.8 64.7  12.0 <0.001
Men 140 (66.0%) 157 (74.1%) 166 (78.3%) 153 (72.2%) 0.083
BMI (kg/m2) 25.9  3.7 26.9  4.4 27.3  4.4 27.2  4.3 0.01
Medical history
Hypertension 82 (38.7%) 86 (40.6%) 96 (45.3%) 109 (51.4%) 0.002
Previous MI 22 (10.4%) 20 (9.4%) 27 (12.7%) 20 (9.4%) 0.42
Diabetes 19 (9.0%) 24 (11.3%) 23 (10.8%) 34 (16.0%) 0.04
Smoking 151 (71.2%) 146 (68.9%) 154 (72.6%) 137 (64.6%) 0.13
Heart failure 6 (2.8%) 5 (2.4%) 6 (2.8%) 11 (5.2%) 0.08
eGFR (ml/min/1.73 m2) 83.2  9.9 80.0  11.8 80.5  14.6 77.4  16.4 <0.001
Troponin T (ng/ml) 1.6  2.1 3.0  3.5 3.4  4.0 5.7  4.9 <0.001
Killip class >1 4 (1.9%) 15 (7.1%) 20 (9.4%) 47 (22.2%) <0.001
Heart rate (beats/min) 66.6  10.3 69  11.4 71.3  11.9 77.1  12.7 <0.001
Blood pressure (mm Hg)
Systolic 131  19 134  22 131  20 126  20 <0.001
Diastolic 79  11 80  13 80  11 80  12 0.19
Infarct classiﬁcation
Non-STEMI 92 (43.4%) 66 (31.1%) 66 (31.1%) 48 (22.6%) <0.001
STEMI 120 (56.6%) 146 (68.9%) 146 (68.9%) 164 (77.4%) <0.001
LAD involvement 42 (19.9%) 58 (27.4%) 78 (36.8%) 136 (63.7%) <0.001
Multivessel disease 23 (10.8%) 20 (9.4%) 32 (15.1%) 37 (17.5%) 0.01
Intervention 0.03
Primary PCI 113 (53.3%) 133 (62.7%) 133 (62.7%) 147 (69.3%)
Subacute PCI 40 (18.9%) 40 (18.9%) 34 (16.1%) 32 (15.1%)
No PCI 59 (27.8%) 39 (18.4%) 45 (21.2%) 33 (15.6%)
Additional CABG 14 (6.6%) 13 (6.1%) 19 (9.0%) 17 (8.0%) 0.20
Values are mean  SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass grafting; eGFR ¼ estimated glomerular ﬁltration rate; GLS ¼ global longitudinal strain; LAD ¼ left
anterior descending coronary artery; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention;
STEMI ¼ ST-segment elevation myocardial infarction.
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assessed by Killip class >1, proportion of STEMI, left ante-
rior descending coronary artery involvement, and multivessel
disease.Table 2 Baseline Echocardiographic Characteristics
Characteristic
<16.7
(n ¼ 212)
16.7 to 14.
(n ¼ 212)
LVEDV (ml) 81  24 82  22
LVESV (ml) 34  13 37  13
LVEF (%) 58  7 55  7
WMSI 1.2  0.2 1.3  0.2
LVMi (g/m2) 84  19 87  20
LAVi (ml/m2) 35  12 34  9
E/e0 ratio 9.1  3.0 9.8  3.3
E/A ratio 1.1  0.4 1.0  0.3
MV DT (ms) 199.9  46.0 199.3  50.4
Moderate to severe MR 3 (1.4%) 3 (1.4%)
TR PG (mm Hg) 20.3  10.2 19.8  10.5
TAPSE (cm) 2.4  0.4 2.3  0.4
Values are mean  SD or n (%).
DT ¼ deceleration time; LAVi ¼ left atrial end-diastolic volume index; LVEDV ¼
volume; LVMi ¼ left ventricular mass index; MR ¼ mitral regurgitation; MV ¼ m
excursion; TR ¼ tricuspid regurgitation; WMSI ¼ wall motion score index; otherThe relationships between echocardiographic parameters
and quartiles of GLS are shown in Table 2. Progressively
impaired GLS was signiﬁcantly associated with increased
LV dilation, increased LVMI, reduced LVEF, and higherAccording to Quartiles of GLS
GLS (%)
p Value
6 14.6 to 12.1
(n ¼ 213)
>12.1
(n ¼ 212)
86  24 87  27 0.046
41  15 45  17 <0.001
52  7 49  7 <0.001
1.4  0.2 1.6  0.2 <0.001
88  23 96  28 <0.001
33  11 34  10 0.39
10.2  3.9 11.9  4.8 <0.001
1.0  0.4 1.0  0.5 0.37
193.9  48.0 177.3  52.5 <0.001
6 (2.8%) 8 (3.8%) 0.38
18.5  9.4 20.7  11.1 0.19
2.1  0.4 2.0  0.4 <0.001
left ventricular end-diastolic volume; LVESV ¼ left ventricular end-systolic
itral valve; PG ¼ peak gradient; TAPSE ¼ tricuspid annular plane systolic
abbreviations as in Table 1.
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impaired GLS, but LAVI was not signiﬁcantly associated
with impaired GLS.
Prognostic value of GLS. During follow-up (median
30.0 months; interquartile range: 24.3 to 32.8 months),
57 patients (6.7%) reached the composite endpoint
(42 patients [5.0%] died and 15 patients [2.0%] were
hospitalized for HF), and no patients were lost to follow-up.
A cutoff value of GLS >14% (hazard ratio [HR]: 3.21;
95% conﬁdence interval [CI]: 1.82 to 5.67; p < 0.001)
maximized the partial likelihood and identiﬁed 373 patients,
of whom a cumulative 7.5% and 10% experienced the
combined endpoint by 12 and 24 months, respectively. In
contrast, a cumulative 2% and 3% of patients with
GLS <14% (n ¼ 475) experienced the combined end-
point at 12 and 24 months, respectively. The Kaplan-Meier
estimate dichotomized according to GLS >14% is re-
ported in Figure 1 (log-rank chi-square ¼ 18.1, p < 0.0001).
In univariate analyses, GLS provided the second highest
C-statistic, surpassed only by age, and after backward
elimination, GLS remained signiﬁcant along with age,
eGFR, and a restrictive ﬁlling pattern (mitral valve decel-
eration time <140 ms) (Table 3).
GLS continued to be an independent predictor of the
composite endpoint when adjusted for LAVI, E/e0 ratio,
moderate to severe MR, LVEF, LVMI, and WMSI
(Table 4), but the E/e0 ratio was the only covariate thatFigure 1
Kaplan-Meier Curve Showing Freedom From the
Combined Endpoint in 848 Patients With
LVEFs >40% After Myocardial Infarction
Patients with global longitudinal strain (GLS)> 14% (n ¼ 373) had increased risk
for the combined endpoint of all-cause mortality and heart failure admission
(p < 0.001). Time indicates months after echocardiography in relation to the
myocardial infarction.maintained an independent prognostic value (p ¼ 0.01),
while LAVI was only borderline signiﬁcant (p ¼ 0.06).
When adjusted for age, diabetes, history of hypertension,
Killip class >1, troponin, eGFR, and infarct classiﬁcation,
GLS continued to have independent prognostic value (HR:
1.14; 95% CI: 1.04 to 1.26; p ¼ 0.007), and only age (HR:
1.05; 95% CI: 1.03 to 1.08; p < 0.001) and eGFR (per 10
ml/m2 decrease, HR: 1.17; 95% CI: 1.01 to 1.36) main-
tained signiﬁcant prognostic value along with GLS
(Table 4). Addition of GLS to the clinical covariates
signiﬁcantly increased the 2 log likelihood (p ¼ 0.006).
Added value of GLS in relation to predicting outcome.
Reclassiﬁcation analysis of adding GLS to LVEF and
WMSI yielded a signiﬁcant IDI (0.89%, p ¼ 0.012) and
NRI (0.20, p ¼ 0.014), driven both by correct net upward
risk reclassiﬁcation in patients with events (NRIevent ¼ 0.16,
p ¼ 0.040) and correct net downward reclassiﬁcation in
those without events (NRInonevent ¼ 0.05, p ¼ 0.032)
(Table 5). When adding GLS >14% to a model consisting
of Killip class >1, diabetes, LVEF, and WMSI, a signiﬁcant
increase in IDI occurred (0.82%, p ¼ 0.009), whereas NRI
was only borderline statistically signiﬁcant (0.11, p ¼ 0.09).
GLS in relation to cause-speciﬁc outcomes. A total of
21 patients (2.5%) died of cardiac causes, and noncardiac
death occurred in 22 patients (2.6%). In univariate analysis,
GLS was signiﬁcantly associated with both cardiac death (HR:
1.37; 95% CI: 1.17 to 1.61; p < 0.001) and HF hospitali-
zation (HR: 1.52; 95% CI: 1.23 to 1.87; p < 0.001), and
GLS >14% was associated with 12-fold and 5-fold
increases in risk for cardiac death (HR: 12.7; 95% CI: 2.95
to 54.57; p < 0.001) (Fig. 2) and HF admission (HR: 5.31;
95% CI: 1.50 to 18.82; p < 0.001) (Fig. 3), respectively,
whereas GLS >14% was not associated with noncardiac
death (Fig. 2). After multivariate adjustment with clinical
covariates, GLS remained an independent predictor of both
cardiac death and HF admission (Table 5). There was no
prognostic value of GLS, LVEF, diabetes, Killip class>1, or
infarct classiﬁcation for noncardiovascular death (p > 0.10
for all), but as expected, both age and eGFR were prognostic.
A total of 44 patients (5.2%) had new MIs, and neither GLS
(HR: 1.07; 95% CI: 0.98 to 1.15; p¼ 0.19) nor LVEF (HR:
0.96; 95% CI: 0.93 to 1.01; p ¼ 0.07) contained prognostic
information in relation to the risk for reinfarction, but as
expected, diabetes was highly prognostic (HR: 4.64; 95% CI:
2.51 to 8.59; p < 0.001).
Finally, Bland-Altman analysis demonstrated a good
intraobserver and interobserver agreement, with a small
nonsigniﬁcant bias for GLS. The mean difference  2 SDs
for GLS was 0.7  2.5% and 0.5  1.3% for interob-
server and intraobserver agreement, respectively.
Discussion
In the largest prospective study to date of patients with MIs
undergoing comprehensive echocardiography with defor-
mation imaging, we demonstrate the following: 1) GLS
Table 3
Univariate and Multivariate Results of Combined Clinical and
Echocardiographic Cox Regression Models
Variable HR 95% CI p Value C-Statistic HR 95% CI p Value
Age, yrs 1.07 1.05–1.10 <0.001 0.72 1.06 1.03–1.08 <0.001
Diabetes 2.00 1.06–3.78 0.033 0.54
Hypertension 1.66 0.99–2.81 0.057 0.56
Killip class >1 3.43 1.90–6.20 <0.001 0.58
Infarct classiﬁcation 0.87 0.51–1.50 0.628 0.51
eGFR per 10 ml/m2 decrease 1.37 1.20–1.57 <0.001 0.64 1.17 1.01–1.36 0.036
Troponin 1.07 1.01–1.14 0.039 0.52
LVEF 0.96 0.92–0.99 0.014 0.60
WMSI 4.82 1.80–12.93 0.002 0.62
E/e0 ratio 1.10 1.06–1.15 <0.001 0.60
LAVi 1.03 1.01–1.05 0.007 0.61
MV DT <140 ms 1.96 1.05–3.63 0.034 0.55 1.94 1.02–3.72 0.044
LVMi 1.01 1.00–1.02 0.189 0.58
Moderate to severe MR 2.52 0.79–8.10 0.119 0.52
GLS 1.20 1.10–1.32 <0.001 0.65 1.12 1.02–1.22 0.016
CI ¼ conﬁdence interval; HR ¼ hazard ratio. Other abbreviations as in Tables 1 and 2.
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2370calculated using a semiautomatic algorithm available as
a bedside tool without the need for time-consuming post-
processing enables rapid risk assessment and predicts adverse
outcome in patients with LVEFs >40%; and 2) GLS
provides independent information related to death or HF
admissions in patients with LVEFs >40% over and above
well-established risk factors that carry treatment recom-
mendations in current guidelines. Randomized studies
should clarify whether patients with MIs, LVEFs>40%,
and impaired GLS beneﬁt from antiremodeling therapy.
GLS in relation to myocardial function and prognosis
after MI. The prognostic value of GLS may in part be
determined by the ability of GLS to reﬂect infarct size after
MI, which has been demonstrated in several studies (5,6).
Subendocardial longitudinal ﬁbers are sensitive to hypo-
perfusion in the setting of ischemia, so GLS may also reﬂect
the area at risk. However, impaired GLS may be seen even in
the absence of signiﬁcant acute myocardial injury, when pre-
existing conditions adversely affect longitudinal ﬁber func-
tion, such as ﬁbrosis and triglyceride depositions (19,20).
Furthermore, the geometric alignment of the endocardial
longitudinal ﬁbers results in a smaller curvature and thus
exposes them to greater detrimental effect of increased LV
cavity pressure because of the law of Laplace (4).
Estimation of LVEF, whether performed by Simpson’s
method or qualitative scoring of myocardial segments, is aTable 4 Relation Between GLS and Outcome
Outcome
Number of Events/
Number of Patients Unadjusted HR
All-cause death or hospitalization for HF 57/849 (6.7%) 1.20 (1.10–1.32),
Cardiac death 21/849 (2.5%) 1.37 (1.17–1.61),
Hospitalization for HF 15/849 (1.8%) 1.52 (1.23–1.87),
*Adjusted for left atrial volume index, E/e0 ratio, left ventricular mass index, moderate-to-severe mitral re
class >1, estimated glomerular ﬁltration rate, troponin, and infarct classiﬁcation.
HF ¼ heart failure; other abbreviations as in Tables 1 and 3.cornerstone in decision making after MI. Currently, anti-
remodeling treatment after acute MI with angiotensin-
converting enzyme inhibitors is indicated in all patients
with LVEFs<40% to 45%. Patients with diabetes or
in-hospital HF represent a high-risk group even in the
setting of an LVEF >40% and as such should also receive
angiotensin-converting enzyme inhibitors (17). Aldosterone
antagonist treatment is indicated for patients with LVEFs
<40% accompanied by in-hospital HF or diabetes (3).
Thus, any novel measure of LV systolic dysfunction after
acute MI should preferentially be applied in a population
with LVEFs>40%, for whom treatment guidelines are
less clear. The present study demonstrates that impaired
GLS identiﬁes high-risk patients in the setting of LVEF
>40% independently and incremental to Killip class >1,
diabetes, LVEF, and WMSI, which are among the most
important decision-making indexes in patients with acute
MIs and LVEFs >40%. Reclassiﬁcation analysis of GLS
with arbitrary risk categories yielded signiﬁcant improve-
ment over LVEF and WMSI, underscoring the powerful
insight into LV dysfunction provided by deformation
analysis.
GLS in patients with LVEFs >40%. In the present study,
patients with preserved or only modestly reduced LVEFs
constituted nearly 85% of our overall population with acute
MIs available for analysis and carried a low absolute risk forGLS
(95% CI)
Adjusted for Echocardiographic
Covariates, HR (95% CI)*
Multivariate Adjusted
HR (95% CI)y
p < 0.001 1.15 (1.03–1.29), p ¼ 0.01 1.14 (1.04–1.26), p ¼ 0.007
p < 0.001 1.31 (1.07–1.60), p ¼ 0.009 1.26 (1.06–1.50), p ¼ 0.009
p < 0.001 1.27 (0.99–1.63), p ¼ 0.06 1.47 (1.17–1.86), p < 0.001
gurgitation, and wall motion score index. yAdjusted for age, diabetes, history of hypertension, Killip
Figure 3
Cumulative Incidence Curve for HF Admission With
Adjustment for Competing Risk From Death From
All Causes
The red and black curves depict heart failure (HF) admissions stratiﬁed according
to global longitudinal strain (GLS) >14% (p < 0.001).
Table 5
Reclassiﬁcation Table With Added Value of GLS in
Relation to Outcome
Model With LVEF and WMSI
Model With LVEF, WMSI, and GLS
0%–5%
Risk
5%–10%
Risk
>10%
Risk Total
Patients with endpoint
0%–5% risk 7 6 0 13
5%–10% risk 4 17 9 30
>10% risk 0 2 12 14
Total 11 25 21 57
Patients without endpoint
0%–5% risk 204 58 0 262
5%–10% risk 129 234 61 429
>10% risk 2 28 71 101
Total 335 320 137 792
Net reclassiﬁcation improvement ¼ 0.20 (p ¼ 0.014).
Abbreviations as in Tables 1 and 2.
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However, assessment of GLS using a semiautomatic algo-
rithm and a cutoff of 14% enabled the identiﬁcation of
a smaller subgroup with 3 times higher risk for the combined
endpoint, 12 times higher risk for cardiac death, and 5 times
higher risk for HF hospitalization, and, importantly, the
remaining large group had very favorable outcomes.
Several studies have examined the prognostic value of
GLS in unselected populations (21), in stable chronic HF
(9,22,23), and recently in patients with chronic ischemic
cardiomyopathy (24). The prognostic value of GLS was
reported by Hung et al. (11) in 603 high-risk patients withFigure 2
Cumulative Incidence Curve for Cardiac Death With
Adjustment for Competing Risk
The red and black curves depict cardiac death stratiﬁed according to global
longitudinal strain (GLS) >14% (p < 0.001). The blue and green curves show
death from other causes stratiﬁed according to GLS >14%, with no signiﬁcant
prognostic value of GLS.MIs from the Valsartan in Acute Myocardial Infarction
study, and both Munk et al. (12) (n ¼ 425) and Antoni et al.
(10) (n ¼ 659) demonstrated the prognostic value in
STEMI. However, all of these studies were of smaller size,
were retrospective in design, and used a time-consuming
algorithm for calculating GLS. Furthermore, the studies in
STEMI both used reinfarction in the combined endpoint,
which was predicted by neither GLS nor LVEF in our
study. The study by Munk et al. (12) was pooled from 3
smaller studies and had 75% feasibility for GLS calculation.
The combined secondary endpoint in the study by Antoni
et al. was driven in large part by elective revascularization,
which can often be anticipated from the coronary anatomy
obtained at baseline. Furthermore, none of the studies
speciﬁcally studied a population with preserved or only
moderately reduced LVEFs. Finally, the present study is
sufﬁciently large to evaluate the prognostic value of GLS on
highly relevant endpoints in a low-risk MI population, for
which there are currently no established guidelines for
antiremodeling therapies.
Relative importance of GLS compared with diastolic
parameters. GLS maintained signiﬁcant prognostic value
when adjusted for E/e0 ratio, WMSI, LVEF, and LAVI,
and only E/e0 retained prognostic information. Limited data
exist on the combined prognostic value of E/e0 ratio and
LAVI in contemporary patients with MIs with LVEFs
>40%, but from a physiological point of view, a chronically
enlarged left atrium in the absence of MR must imply at
least periodically elevated ﬁlling pressure (25). The impact of
longitudinal myocardial shortening in relation to left atrial
Ersbøll et al. JACC Vol. 61, No. 23, 2013
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2372volume has not been explored in detail. Further studies are
needed to assess the interaction among left atrial volume,
E/e0 ratio, and GLS in contemporarily managed patients
with MIs with normal to modestly reduced LVEFs.
GLS in relation to hospitalization for HF and cardiac
death. In patients with LVEFs >40%, GLS proved to be
predictive of HF hospitalizations, with an unadjusted 5-fold
increase in risk according to the optimal cutoff values.
This ﬁnding is in line with emerging evidence from studies
of patients with HF with preserved ejection fraction, in
whom distinct systolic abnormalities are apparent despite
preserved LVEFs (8). Indeed, in-hospital HF in the acute
phase of MI has been shown to be highly associated with
GLS (26) and biochemical evidence of neurohormonal
activation (27). Although the absolute risk for HF hospi-
talization in patients with LVEFs >40% was low, the
striking independent effect of GLS in this regard warrants
further studies of the coupling of reduced long-axis function
in the acute phase of MI and subsequent disposition for
elevations in ﬁlling pressure. The association between GLS
and cardiac death remains intriguing, and further studies
should be conducted to examine the relationship between
deformation patterns in acute MI and disposition for
malignant arrhythmias.
Study limitations. Although the present study encom-
passes the largest population to date with MI and prospec-
tive evaluation of GLS in the acute phase, we acknowledge
that the feasibility of the semiautomated GLS measurements
may have been higher in our case compared with everyday
clinical practice. However, recent studies suggest that GLS
can be estimated with good reproducibility across different
vendor platforms and proprietary software algorithms (28).
The multivariate statistical models suffer from overﬁtting
due to the small number of events, which warrant caution for
the interpretation, but this strategy can be acceptable when
the main focus is on controlling for confounders rather than
building prediction models (29). In this study, we did not
perform analyses of radial and circumferential deformation,
which has previously been shown to contain prognostic
information (11), but a number of considerations pertain to
this decision: 1) circumferential and radial strain calculations
require sufﬁcient short-axis images, ideally at the apical,
midpapillary, and mitral levels, which are not always possible
to obtain; 2) currently, there is no validated global value for
circumferential strain; and 3) currently, no semiautomatic
algorithm exists for these calculations. We did not calculate
strain rate, because it is not currently available in the semi-
automated algorithms. In this study, we enrolled patients
with STEMI and those with non-STEMI, but none of the
major clinical trials evaluating renin-angiotensin blockade
(2,17), aldosterone blockade (3), and device therapy (30,31)
in post-MI patients have used the type of infarction as
a selection criterion, so no evidence supports a differential
importance of systolic dysfunction according to infarct
transmurality. None of the echocardiographic exams were
performed using contrast, which could potentially haveimproved image quality and altered the prognostic value of
the traditional echocardiographic measurements.
Conclusions
Semiautomated calculation of GLS is signiﬁcantly related to
all-cause mortality or HF admission in patients with MIs
and LVEFs >40%, above and beyond traditional identiﬁers
of high risk such as diabetes and clinical HF.
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